Sensa supports weight-loss claims
This article was originally published in The Tan Sheet
Executive Summary
Supplement marketer Sensa Products substantiates claims its weight-loss product Sensa "works with your body's natural impulses" and "was proven effective in one of the largest clinical studies ever performed on a non-prescription weight-loss product," the National Advertising Division says in a report Sept. 3. The Council of Better Business Bureaus division notes a clinical study of the weight-loss product included 1,436 participants who lost an average of 30.5 pounds in six months as advertised. NAD recommends the firm discontinue testimonials on Sensa's Web site that say people who took Sensa lost 70 or 120 pounds. NAD says the testimonials are misleading when paired with claims based on studies. Manhattan Beach, Calif.-based Sensa says it will consider NAD's recommendation
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.